Aimia Inc.

The deployment of roughly half the Bozzetto sale proceeds to retire $131.4 million in Senior Notes strengthens the balance sheet, while the remaining ~$137 million earmarked for share repurchases and investments signals disciplined capital stewardship that could unlock meaningful shareholder value.

With the company holding a large cash balance post-Bozzetto and no clearly defined investment pipeline, there is uncertainty about whether management can redeploy capital into value-accretive opportunities, raising concerns that returns will be diluted by prolonged inactivity or suboptimal acquisitions.

Aimia trades at C$2.73–$2.75, a meaningful discount to its pro forma book value per share of $3.66 once the Bozzetto sale closes. The active NCIB — with up to 5,012,419 shares approved for cancellation through June 2027 — directly addresses this gap and should support the share price.

Despite ongoing buybacks and a stated belief that shares trade below intrinsic value, the stock has remained persistently depressed at around C$2.70, suggesting the market is skeptical about the company's strategic direction and that repurchases alone are insufficient to catalyze a meaningful re-rating.

With tax losses estimated at an additional $1–$2 per share in value and a clean balance sheet following the Bozzetto divestiture, Aimia is well-positioned as a capital allocator to pursue high-return investments, offering investors a flexible and opportunistic holding company structure.

After divesting its core specialty chemicals business, Aimia lacks a clearly defined operating identity. The absence of a concrete investment mandate or sector focus makes it difficult for analysts to model future earnings, leaving the stock vulnerable to a conglomerate discount and investor indifference.